AUS
NZ
UK
CA
USA
IND
DiagnaMed Holdings Corp. (CSE: DMED) has renewed and expanded its strategic technical advisory partnership with Quebec Innovative Materials Corp. to expedite exploration of its Canadian natural hydrogen assets. This enhanced collaboration will concentrate on densification and geophysical surveys at the Temiskaming Project in Ontario, where an 11-kilometre hydrogen trend has been established, while simultaneously initiating the inaugural systematic exploration program on the newly acquired 2,104-claim Colchester East Project located in Nova Scotia's Cumberland Basin.
Key Points
- DiagnaMed Holdings Corp. (CSE: DMED) has broadened its collaboration with Quebec Innovative Materials Corp. (QIMC) to accelerate natural hydrogen exploration efforts.
- Previous exploration in Ontario revealed hydrogen soil gas anomalies surpassing 2,000 ppm, defining an 11-kilometre hydrogen-bearing corridor at the Temiskaming Project.
- Upcoming phases include infill soil gas sampling and geophysical surveys in Ontario, alongside the first exploration campaign on the 2,104-claim Colchester East Project in Nova Scotia.
- Investors should watch for key milestones such as completion of sampling programs, lab analyses, and identification of priority drill targets expected during the current field season.
Renewed Partnership Accelerates Natural Hydrogen Exploration Strategy
On July 23, 2026, DiagnaMed announced the extension of its technical advisory agreement with QIMC, enabling advancement of its natural hydrogen portfolio across two prime Canadian jurisdictions. This renewal underscores a strategic commitment to systematically assess natural hydrogen systems through a disciplined, science-based exploration methodology. The extension follows notable exploration achievements over the past year, indicating sufficient progress to justify advancing to detailed evaluation stages.
This continuation builds on a collaboration that has already yielded tangible exploration results. By formalizing expanded work across both existing and newly acquired properties, DiagnaMed is gaining momentum in the emerging Canadian natural hydrogen sector. The decision to deepen the partnership with QIMC, recognized as a leading natural hydrogen explorer in Canada, reflects strong confidence in the firm’s technical expertise and exploration approach.
Ontario Hydrogen Trend Grows to 11 Kilometres, Moving from Reconnaissance to Target Definition
Exploration at DiagnaMed’s Temiskaming Natural Hydrogen Project in Ontario has uncovered multiple naturally occurring hydrogen soil gas anomalies. The company reported hydrogen concentrations exceeding 2,000 ppm in sampled zones, providing measurable evidence of hydrogen presence. These findings have extended the known hydrogen-bearing corridor to over 11 kilometres, a significant expansion beyond initial reconnaissance efforts.
This shift from regional reconnaissance to identifying an extensive hydrogen system marks increased project maturity. The 11-kilometre trend offers compelling evidence of a large-scale hydrogen system within the Temiskaming Graben, forming the basis for a detailed exploration phase focused on defining priority targets. Upcoming work will involve densification (infill) soil gas sampling and geophysical surveys to better characterize anomaly geometry and understand structural controls on hydrogen migration.
Colchester East Project Initiates First Exploration Program in Nova Scotia’s Cumberland Basin
Alongside Ontario activities, QIMC will launch the inaugural soil gas sampling on DiagnaMed’s recently acquired Colchester East Natural Hydrogen Project. This property includes 30 exploration licences covering 2,104 mineral claims in Nova Scotia’s prospective Cumberland Basin. Situated along the regional Cumberland Fault system—a significant geological feature favorable for natural hydrogen generation and migration—the property represents a greenfield exploration target with discovery potential.
The Nova Scotia program will establish the first systematic geochemical dataset for Colchester East, aiding identification of areas for detailed follow-up. As the initial exploration on this newly acquired asset, it will provide baseline geochemical data to guide further exploration if results are promising. The company has not disclosed the acquisition timing or capital allocated for this survey.
QIMC’s Technical Expertise and Proprietary Exploration Techniques
Under the extended agreement, QIMC will deliver comprehensive advisory services including exploration planning, field supervision, soil gas sampling, geoscientific interpretation, structural analysis, and integration of geological and geochemical data to support drill target generation. This full-cycle approach transforms raw exploration data into actionable drilling targets. QIMC’s role extends beyond sample collection to encompass interpretative frameworks prioritizing exploration efforts.
The announcement highlights QIMC’s pioneering methodologies that combine structural geology, soil gas geochemistry, and proprietary targeting models to identify natural hydrogen systems. Their technical team has successfully applied these methods across multiple Canadian sedimentary basins, including Quebec and Nova Scotia, enhancing understanding of Canada’s natural hydrogen potential. QIMC’s proven expertise positions it as a vital partner in DiagnaMed’s exploration strategy.
Management Insights on Portfolio Diversification and Long-Term Growth
John Karagiannidis, CEO of DiagnaMed, stated that the partnership with QIMC has enabled rapid advancement of one of Canada’s emerging natural hydrogen portfolios. He noted progress in Ontario from regional reconnaissance to defining a substantial hydrogen system now ready for detailed infill exploration and geophysical analysis. Karagiannidis emphasized that the Colchester East acquisition offers exposure to another highly prospective geological setting within Nova Scotia’s Cumberland Basin.
The CEO explained that advancing exploration in two of Canada’s most promising natural hydrogen regions allows systematic evaluation of multiple hydrogen accumulation opportunities. He described the next phase as converting encouraging regional results into refined targets to guide future exploration and build long-term shareholder value. This underscores management’s view that current efforts pave the way for potential drilling and resource definition if results remain positive.
Robust Exploration Pipeline and Anticipated Field Season Milestones
Combining advanced target refinement in Ontario with first-pass exploration in Nova Scotia provides DiagnaMed with a diversified pipeline of catalysts expected throughout the current field season. Upcoming milestones include completion of Ontario’s infill soil gas sampling, the inaugural Colchester East soil gas survey, laboratory analyses, integrated geological and geochemical interpretation, and delineation of priority drill targets.
This structured timeline offers investors a clear roadmap to track progress from field data collection through analysis to target identification. The announcement does not specify exact completion dates or budget allocations between Ontario and Nova Scotia programs, requiring investors to monitor future updates.
Natural Hydrogen: A Growing Exploration Frontier in Canada
Natural hydrogen exploration remains a nascent segment within Canadian mineral exploration, distinct from traditional hydrocarbons. The focus on soil gas geochemistry and structural controls reflects adaptation of oil and gas exploration techniques to identify naturally occurring hydrogen accumulations. Targeting two distinct geological settings—the Temiskaming Graben in Ontario and Cumberland Basin in Nova Scotia—demonstrates a strategic approach to evaluate hydrogen potential across varied basin types and structural regimes.
DiagnaMed’s emphasis on clean natural hydrogen resources identified through rigorous scientific exploration positions it within an early-stage sector. The company’s reliance on expert partnerships rather than solely internal capabilities highlights a pragmatic strategy to navigate this technically challenging field. The announcement does not provide production forecasts, commercial viability assessments, or timelines for resource definition or development.
Competitive Edge in Canada’s Natural Hydrogen Market
By extending its partnership with QIMC, DiagnaMed aligns with a firm recognized as a leader in Canada’s natural hydrogen industry. This strategy leverages specialist expertise to compete effectively in an emerging market. Operating across two geological jurisdictions reduces concentration risk and broadens exposure to Ontario and Nova Scotia hydrogen systems.
Disclosure of hydrogen concentrations exceeding 2,000 ppm and an 11-kilometre trend in Ontario offers quantifiable metrics to communicate exploration progress to investors. These baseline results may support future capital raising by demonstrating tangible achievements. The company has not shared peer comparisons or metrics to independently assess the significance of these findings within the broader natural hydrogen landscape.
Ongoing Exploration and Investor Considerations
Investors should monitor announcements related to outlined milestones, including completion of infill sampling in Ontario and first-pass surveys in Nova Scotia. Laboratory data from these programs will inform subsequent interpretation critical to advancing drill target identification and potential drilling. The company has not disclosed minimum budgets, timelines for drilling, or capital requirements for future phases.
The extension of the QIMC advisory agreement signals management’s commitment to sustained technical investment. Investors should watch for any changes in partnership scope, deviations from the exploration timeline, or capital deployment updates. The company’s ability to meet announced milestones and the quality of QIMC’s interpretations will be evident through forthcoming technical updates and exploration progress reports.
